journal cover

Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs

The Journal of Antimicrobial Chemotherapy

Jun 28, 2005

Kurt Vermeire, Dominique Schols

Download from

Publisher
PubMed

Abstract

It is imperative to continue efforts to identify novel effective therapies that can assist in containing the spread of HIV. Recently acquired knowledge about the HIV entry process points to new strategies to block viral entry. For most HIV strains, the successful infection of their targ...read more

Mentioned in this Paper

T-Lymphocyte
CD4 Antigens
Viral Envelope
Heterocyclic Compounds
HIV Infections
Anti-HIV Agents
Monocytes as Percentage of Blood Leukocytes (Lab Test)
Target Cell Count
Lead compound
Microbicides
Paper Details
References
  • References
  • Citations13
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations13
12

Feeds With Similar Papers

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of Leukocyte Biology

Specific CD4 down-modulating compounds with potent anti-HIV activity

Journal of Leukocyte BiologySeptember 10, 2003
Kurt Vermeire, Dominique Schols
Current HIV Research

CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor

Current HIV ResearchMay 14, 2008
Kurt VermeireDominique Schols
© 2020 Meta ULC. All rights reserved

Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs

The Journal of Antimicrobial Chemotherapy

Jun 28, 2005

Kurt Vermeire, Dominique Schols

PMID: 15980096

DOI: 10.1093/jac/dki208

Abstract

It is imperative to continue efforts to identify novel effective therapies that can assist in containing the spread of HIV. Recently acquired knowledge about the HIV entry process points to new strategies to block viral entry. For most HIV strains, the successful infection of their targ...read more

Mentioned in this Paper

T-Lymphocyte
CD4 Antigens
Viral Envelope
Heterocyclic Compounds
HIV Infections
Anti-HIV Agents
Monocytes as Percentage of Blood Leukocytes (Lab Test)
Target Cell Count
Lead compound
Microbicides

Feeds With Similar Papers

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of Leukocyte Biology

Specific CD4 down-modulating compounds with potent anti-HIV activity

Journal of Leukocyte BiologySeptember 10, 2003
Kurt Vermeire, Dominique Schols
Current HIV Research

CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor

Current HIV ResearchMay 14, 2008
Kurt VermeireDominique Schols
Paper Details
References
  • References
  • Citations13
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations13
12

Download from

Publisher
PubMed
/papers/cyclotriazadisulfonamides-promising-new-cd4-target/15980096